Director sold ~$105K of Krystal Biotech
Scheduled in advanceLoading…
Traded Mar 4, 2026 · Filed Mar 6, 2026
The boss of Krystal Biotech sold $2.33M of Krystal Biotech shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,330,151
Shares × reported transaction price
15 days after results of Feb 17, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.3% | −1.4% | −1.9% |
| 30 days | +2.1% | −0.3% | +2.5% |
| 90 days | +16.7% | +9.0% | +7.7% |
| 180 days | +35.8% | +12.9% | +22.9% |
Past results only. Not a forecast.
Director sold ~$105K of Krystal Biotech
Scheduled in advanceDirector sold ~$152K of Krystal Biotech
Automatic saleDirector sold ~$173K of Krystal Biotech
Automatic sale